A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction

A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction Among Egyptian Females

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03012152

Enrollment

Registered

2017-01-06

Start date

2012-09-30

Completion date

2016-09-30

Last updated

2017-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastcancer

Keywords

Oncoplastic surgery, Standard conservative surgery, Patient satisfaction, Margin Status

Brief summary

This non randomized study is a comparative study between standard conservative breast surgery and oncoplastic surgery as regard margin status and patient satisfaction.

Detailed description

This planned study was conducted on 70 female patients presented to our tertiary referral breast unit at Ain Shams University hospitals with breast cancer amid the period from September 2012 to May 2013 . Every one of them signed an informed consent to partake in this study that was approved in a meeting held by the ethical committee on august 2012 at Ain Shams University. All patients sharing in the study received closed envelope before surgery in a randomized way in which the surgical technique is written either standard conservative surgery or oncoplastic surgery(Double Blind). Our patients were partitioned into 2 equal groups: group A (35patients) who underwent standard conservative surgery, group B (35patients) who underwent oncoplastic surgery.

Interventions

PROCEDUREStandard conservative breast surgery

PROCEDUREOncoplastic breast surgery

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

No minimum to 60 Years

Healthy volunteers

Inclusion criteria

* Female Patients with stage 1,2 breast cancer.

Exclusion criteria

* Patients \>60 years. * Patients with previous breast surgery. * patients candidate for mastectomy or palliative excision. Patients with collagen disease.

Design outcomes

Primary

Measure	Time frame
Margins in all specimens measured in millimeters 2.	2 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026